View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 200, Small Cell Lung Cancer, Cycle 5+
Protocol-ID: 2916 V1.0 (Mini), TISL200, SCLC, C5+Indication(s)
- Lung Carcinoma, Small Cell; ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 20.05.2025